Previous Close | 14.42 |
Open | 14.46 |
Bid | 13.56 x 600 |
Ask | 13.62 x 1200 |
Day's Range | 13.18 - 14.70 |
52 Week Range | 3.53 - 23.86 |
Volume | |
Avg. Volume | 6,800,101 |
Market Cap | 2.179B |
Beta (5Y Monthly) | 2.03 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.62 |
Earnings Date | Nov 07, 2024 - Nov 11, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 20.00 |
Novavax stock remains volatile. After hitting a two-year high in June on enthusiasm for its updated Covid vaccine, shares have pulled back.
Novavax (NVAX) concluded the recent trading session at $14.42, signifying a -1.77% move from its prior day's close.
Novavax (NVAX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.